Propanc Biopharma Inc. (PPCB)
NASDAQ · Healthcare
Propanc Biopharma Inc. Total Liabilities 2020–2025
Propanc Biopharma Inc. annual total liabilities history from 2020 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Propanc Biopharma Inc. total liabilities as of June 30, 2025: 5.7M, a 48.66% increase year-over-year.
- Propanc Biopharma Inc. total liabilities for 2025 were 5.7M, a 48.66% increase from 2024.
- Propanc Biopharma Inc. total liabilities for 2024 were 3.9M, a 21.21% increase from 2023.
- Propanc Biopharma Inc. total liabilities for 2023 were 3.2M, a 2.33% increase from 2022.
- Propanc Biopharma Inc. total liabilities for 2022 were 3.1M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Propanc Biopharma Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $6 |
| 2024 | $4 |
| 2023 | $3 |
| 2022 | $3 |
| 2021 | $3 |
| 2020 | $4 |
Propanc Biopharma Inc. Total Liabilities — FAQ
Propanc Biopharma Inc. (PPCB) total liabilities over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PPCB's total liabilities history?
The chart and table above show Propanc Biopharma Inc.'s total liabilities by year and by quarter, including the growth rate.